PRRT2 and diabetes mellitus: Research shows that Chelerythrine can activate endogenous CSE/H2S through PKC/NF- κB, thereby reducing oxidative stress and protecting myocardial injury caused by renal ischemia-reperfusion injury in diabetes (45).